Terminalia catappa Linn. is known for its nutritional fruit and possesses medicinal benefits
as well. This is a comprehensive review of the phytoconstituents and pharmacological …

Beta-hemoglobinopathies exhibit a heterogeneous clinical picture with varying degrees of
clinical severity. Pertaining to the limited treatment options available, where blood …

Background: Atherosclerosis is a chronic pathological condition that has remained clinically
silent for decades, and the epidemic has continued to be on the rise due to risk factors …

Inherited beta-thalassemia is caused by irregular production of hemoglobin through
reducing beta-globin chains. It has been observed that increasing fetal hemoglobin (HbF) …

Background Foetal haemoglobin (HbF) is a major modifying factor influencing sickle cell
disease (SCD) severity. Despite this, HbF estimation is not routinely done in Nigeria. The …

For the treatment of β‐thalassemia and sickle cell disease (SCD), pharmacological induction
of fetal hemoglobin (HbF) production may be a promising approach. To date, numerous …

With the increase in life expectancy, the prevalence of chronic diseases of the digestive tract,
such as peptic ulcers and inflammatory bowel disease, and the metabolic syndrome …

Background: Sickle cell anemia (SCA) is a major global public health concern. Fetal
hemoglobin level (HbF) is a major modulating factor of the clinical manifestation of the …

Gamma globin induction remains a promising pharmacological therapeutic treatment mode
for sickle cell anemia and beta thalassemia, however Hydroxyurea remains the only FDA …

The genus Terminalia contains some of the most widely used plants in traditional medicine.
Many species possess antifungal, antibacterial, antiviral, antiprotozoal, analgesic …